POTS Subtype Diagnostic Evaluator: Neuropathic vs. Hyperadrenergic vs. Hypovolemic
1. Why Identifying Your POTS Subtype Changes Everything
Postural Orthostatic Tachycardia Syndrome (POTS) is not a single disease; it is a clinical hemodynamic presentation driven by distinct underlying physiological mechanisms. Prescribing a standard POTS treatment without knowing the patient's subtype often leads to clinical failure: for instance, high-dose fludrocortisone or midodrine can precipitate dangerous hypertensive crises in Hyperadrenergic POTS, while beta-blockers without volume expansion can worsen dizziness in Hypovolemic POTS.
This interactive evaluator uses validated autonomic clinical markers—including orthostatic blood pressure deltas, plasma norepinephrine responses, sudomotor symptoms, and volume depletion indices—to determine your primary and secondary POTS phenotypes.
POTS Phenotype Assessment Calculator
Neuropathic POTS (Peripheral Autonomic Denervation)
Your profile strongly aligns with Neuropathic POTS. In this phenotype, sympathetic adrenergic nerves innervating lower extremity blood vessels are partially damaged (confirmed in ~50% of patients via Small Fiber Neuropathy skin punch biopsy). When standing, blood pools rapidly in the mesenteric veins and calves, reducing venous return to the heart and forcing compensatory reflex tachycardia.
- Pyridostigmine (Mestinon): 30–60 mg TID; enhances vagal tone and splanchnic vasoconstriction without raising heart rate.
- Midodrine: 2.5–10 mg TID; selective alpha-1 adrenergic agonist to constrict pooled capacitance veins.
- Fludrocortisone (Florinef): 0.1–0.2 mg daily; mineralocorticoid to expand intravascular plasma volume.
- Abdominal Compression: 3-panel medical elastic binder (20–30 mmHg) compresses the splanchnic reservoir.
- High Sodium Hydration: 5,000–8,000 mg NaCl with 2.5–3L water using WHO Oral Rehydration Salts.
- Counter-Maneuvers: Heel-to-toe pumps, leg crossing, and recumbent horizontal pacing.
2. Clinical Comparison of the Three Primary POTS Subtypes
| Feature / Parameter | Neuropathic POTS | Hyperadrenergic POTS | Hypovolemic POTS |
|---|---|---|---|
| Primary Mechanism | Peripheral sympathetic denervation & SFN | Central sympathetic hyper-drive (↑ Norepinephrine) | Low absolute circulating plasma & erythrocyte volume |
| Standing Blood Pressure | Normal or slight systolic drop | Elevated (≥ 10 mmHg systolic increase) | Narrow pulse pressure, drops if severe |
| Plasma Norepinephrine (Standing) | Normal or low in lower limbs | Markedly elevated (> 600 pg/mL) | Mild compensatory elevation |
| Key Physical Signs | Severe leg acrocyanosis (purple feet), cold skin | Tremors, facial flushing, anxiety surges, palpitations | Extreme unquenchable thirst, rapid urination, dry mucous membranes |
| Preferred First-Line Drugs | Midodrine, Mestinon, Compression | Clonidine, Guanfacine, Ivabradine, Beta-Blockers | Fludrocortisone, High-dose Salt, Desmopressin, IV Saline |